Gilead Sciences is a USA Biopharmaceutical company that employs a layered IP strategy, including compound-of-matter, formulation, and method-of-use patents, with exclusivity in major markets likely extending into the 2030s over the Lenacapavir injectable antiretroviral drug designed for HIV treatment and prevention (PrEP).

In 1973, the US Supreme Court in the case of Roe V Wade ruled that the Constitution of the US protected the right of pregnant women to choose to have an abortion before the point of fetal viability. This decision meant that pregnant women had a constitutional right to terminate pregnancy before the fetus developed enough to live with medical support outside the womb. Even though in the US, it was eventually overturned in a 2022 ruling in the case of Dobbs V Jackson, it continues to have persuasive precedence across the globe.